Tengion Announces Closing of $15.0 Million of Senior Secured Convertible Notes Due 2015
October 10, 2012 - (Tengion) - "Tengion, Inc., a leader in regenerative medicine, today announced the closing of its previously announced private placement of $15.0 million aggregate principal amount of Senior Secured Convertible Notes (the "Notes"), with certain investors, including Celgene Corporation, RA Capital Management LLC, Deerfield Management Company, LP, Bay City Capital and HealthCap. As part of its investment, Celgene Corporation secured a right of first negotiation on the Company's Neo-Urinary Conduit™ program." Read Full Article
